HR7391Referred to Committee

Community Health Center Drug Pricing Protection Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-02-05
Introduced
50
Cosponsors
HR
ⓘ
Type

Sponsor

Jack Bergman
Jack Bergman
Republican · MI · Representative
Votes with party: 98.5% (540 recorded votes)

Full profile: /officials/B001301

Source: Congress.gov · FEC

Cosponsors (50)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-02-05

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would allow community health centers—clinics that serve low-income and uninsured patients—to negotiate directly with drug manufacturers for lower medication prices, similar to how large hospitals and pharmacy chains do now. The goal is to reduce the cost of prescription drugs for patients who rely on these centers for affordable healthcare. The measure affects both the health centers themselves and the patients they serve, particularly those without insurance or with limited income.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.